FDA Roundup: June 16, 2023

SILVER SPRING, Md., June 16, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA posted information on its website regarding the formula for COVID-19 vaccines for the 2023-2024 fall and winter seasons. The FDA has advised manufacturers seeking to update … Read more

FDA Roundup: June 2, 2023

SILVER SPRING, Md., June 2, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA provided an update on medical device reports it received that are reportedly associated with the breakdown or suspected breakdown of the polyester-based polyurethane (PE-PUR) foam used … Read more

Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders USA – English APAC – English

BRII-297, a first-of-its-kind treatment option for anxiety and depressive disorders, has the potential to enable greater therapeutic adherence and convenience for patients DURHAM, N.C. and BEIJING, May 31, 2023 /PRNewswire/ — Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with … Read more

Novavax’s Nuvaxovid™ Receives Positive CHMP Opinion for Full Marketing Authorization for the Prevention of COVID in the EU

GAITHERSBURG, Md., May 26, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that Nuvaxovid™ (NVX-CoV2373) has been recommended for full Marketing Authorization (MA) for use as a primary series in individuals aged 12 and older and as a booster in individuals aged 18 … Read more

Amendment to BAA Outlines New BARDA Funding Opportunities for Next-generation COVID-19 Vaccines, Monoclonal Antibodies, and Antivirals

By Laura Powell, Managing Consultant and Eric Jia-Sobota, Founder CHARLESTON, S.C. , May 19, 2023 /PRNewswire/ — In the latest amendment to its Broad Agency Announcement (BAA), BARDA (Biomedical Advanced Research and Development Authority) is seeking proposals for the development of cost-effective and adaptable therapeutic platforms to treat viral infections, as well as next-generation COVID-19 vaccines. … Read more

Miso Robotics announces Ecolab partnership and investment

Companies to Work Together on Next-Generation Automation and Cleaning Solutions PASADENA, Calif., May 17, 2023 /PRNewswire/ — Today, Miso Robotics – the company transforming the restaurant industry with robotics and intelligent automation – announced a new partnership and multi-million dollar investment from the world’s water, hygiene and infection prevention company, Ecolab. Ecolab + Miso Robotics announce … Read more

Parliamentarians from 23 countries call on G7 leaders to invest in neglected tropical diseases

Uniting to Combat Neglected Tropical Diseases (unitingtocombatntds.org) releases letter signed by 36 Parliamentarians from 23 countries calling on G7 Leaders to invest in NTDs. LONDON, May 17, 2023 /PRNewswire/ — To: Fumio Kishida, Prime Minister, Japan (Host) Joe Biden, President, United StatesEmmanuel Macron, President, FranceGiorgia Meloni, Prime Minister, ItalyOlaf Scholz, Chancellor, GermanyRishi Sunak, Prime Minister, … Read more